Berlin-Chemie AG engages in the manufacture of pharmaceutical products. It offers products for therapeutic areas, which include inflammatory diseases and pain; gastroenterology; neurology; diabetes; cardiovascular diseases; oncology; and viral diseases. The company was founded in 1890 and is headquartered in Berlin, Germany.

Guangzhou Weishengjun Biotechnology Co., Ltd., established on 2017-08-03, Business scope includes research and development of industrial enzyme preparations;Fermentation process optimization technology research and development;Biomass Energy Technology Services;Research and development of compound microbial fertilizer;Bio-organic fertilizer research and development;Biochemical product technology research and development;Medical Research and Experimental Development;Research and development of bio-based materials technology;Manufacturing of bio-based materials;Sales of bio-based materials;Bio-feed R&D;Biomass energy resource database information system platform;Feed Additive Sales;R&D and application of cell technology;Natural science research and experimental development;New material technology promotion service;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Remote Health Management Services;Health Consulting Services(Does not include medical services);Traditional Chinese Medicine Health Care Services(non-medical);Health Care Services(non-medical);Personal Hygiene Sales;Sales of hygiene products and single-use medical products;Daily miscellaneous goods sales;Cosmetics Retail;Cosmetics Wholesale;Eco-environmental material sales;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Supply Chain Management Services;Purchasing agency service;marketing planning;File finishing service;Conference and Exhibition Services;Information Technology Consulting Services;Project planning and public relations services;pharmaceutical production;Drug Wholesale;Drug import and export;Pharmaceutical commissioned production;Drug internet information service;Production of hygiene products and single-use medical products;Health food production;Health food sales;food business;food production;Food Internet Sales(Selling prepackaged food);Food Internet Sales;Feed additive production;Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business

Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ.

Biotest Pharma GmbH engages in the manufacture and distribution of medicinal and pharmaceutical products. The company is headquartered in Dreieich, Germany.

FAPESP is a public foundation, funded by the taxpayer in the State of São Paulo, with the mission to support research projects in higher education and research institutions, in all fields of knowledge. São Paulo has a population of forty million and generates 35% of Brazil’s GNP. The constitution of the State establishes that 1% of all state taxes belong to the foundation and the government transfers these funds monthly. The stability of the funding and the autonomy of the foundation allow for an efficient management of the resources that has had a sizable impact: while São Paulo has 22% of the Brazilian population and 30% of the scientists with a doctorate in the country, the state responds for 52% of the country’s scientific articles published in international journals. The Foundation works in close contact with the scientific community: all proposals are peer reviewed with the help of area panels composed of active researchers. Besides funding research in all fields, the foundation supports large research programs in Biodiversity, Bioenergy, Global Climate Change, and in Neurosciences.

The Board of Trustees of the University of Illinois, part of University of Illinois, is a company headquartered in Urbana, IL, that trusts Except Educational Religious.

Immunosis Pty Ltd. is an Australian private company located in Melbourne that develops pharmaceutical products. Simon Green is the CEO, in this role since 2015.

Octapharma is a privately-owned global human proteins manufacturer headquartered in Lachen, Switzerland. Since its establishment in 1983 the company has been dedicated to improving the lives of patients. Octapharma was founded in 1983 on the fundamental principle of improving the lives of patients. Since then we have remained focused on our collective responsibility for the trust instilled in us by physicians and patients worldwide. In 2012, the Octapharma Board identified the core strategic pillars which will lead to the achievement of the organization’s ambitious long term goals.

Ribapharm, Inc. discovers, develops and markets antiviral and anticancer pharmaceuticals. The company is located in Costa Mesa, CA

Société des Produits Nestlé SA engages in the manufacture and distribution of food, pharmaceutical, medical, and cosmetic products. The company was founded on December 15, 1936 and is headquartered in Vevey, France.